Black Diamond Therapeutics Inc (BDTX)’s stock is trading at $3.26 at the moment marking a rise of 2.04% from the last session close. As of this writing, shares are priced at -47.75% less than their 52-week high of $6.23, and 172.38% over their 52-week low of $1.20.
Further, it is important to consider BDTX stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 2.65.BDTX’s price to book ratio for the most recent quarter was 1.40, resulting in an 1.30 price to cash per share for the period.
How does Black Diamond Therapeutics Inc (BDTX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Black Diamond Therapeutics Inc (BDTX): Earnings History
If we examine Black Diamond Therapeutics Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.19, slashing the consensus of -$0.23. In other words, it beat the consensus by $0.04, resulting in a 18.57% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.19 in contrast with the Outlook of -$0.23. That was a difference of $0.04 and a surprise of 18.57%.
Black Diamond Therapeutics Inc (NASDAQ: BDTX) Ownership Details
I will give a breakdown of the key shareholders in Black Diamond Therapeutics Inc (BDTX). Recent figures show that the company’s insiders hold 0.63% of shares. A total of 122 institutional investors hold shares in the company, making 78.82% of its stock and 79.32% of its float.
Jun 30, 2025, it was reported that the Company’s largest institutional holder is T. Rowe Price Small-Cap Value Fund, Inc. holding total of 2.42 shares that make 4.24% of the company’s total number of shares and are currently priced at 7.89 million.
The securities firm T. Rowe Price Small-Cap Stock Fund, Inc. holds 2.37 shares of BDTX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 4.16%, and the holding percentage of shares is valued at 7.73 million.
